Skip to content
Disclosery

EXANE DERIVATIVES: NXE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NXE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 633,789 NXE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 633,789 shares
    Change vs previous 13F +131,780 shares

    1.3% of the 13F portfolio, value $2,264,848.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 502,009 shares
    Change vs previous 13F -151,771 shares

    0.8% of the 13F portfolio, value $2,839,066.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 653,780 shares
    Change vs previous 13F +518,203 shares

    0.69% of the 13F portfolio, value $2,849,954.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 135,577 shares
    Change vs previous 13F -6,000 shares

    0.16% of the 13F portfolio, value $640,668.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 141,577 shares
    Change vs previous 13F -130,256 shares

    0.13% of the 13F portfolio, value $568,763.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 271,833 shares
    Change vs previous 13F -141,274 shares

    0.29% of the 13F portfolio, value $976,694.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 413,107 shares
    Change vs previous 13F +9,107 shares

    0.34% of the 13F portfolio, value $1,138,132.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 404,000 shares
    Change vs previous 13F not available

    0.23% of the 13F portfolio, value $696,987.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).